HYPERPARATIROSIS AND CARDIOVASCULAR SYSTEM PATHOLOGY
https://doi.org/10.14341/osteo2006233-41
Abstract
For many years, hyperparathyroidism, including primary, primarily associated with severe pathology of the osseous system and kidneys, was considered a rare disease. The widespread introduction into the clinical practice of the determination in the blood of calcium, and then parathyroid hormone, and osteodensitometry made it possible to recognize this disease more often and at earlier stages and to treat it more successfully. By now, the specific gravity of mild and asymptomatic forms of hyperparathyroidism has increased from 10-15% in the 1980s to 80%.
Conservative management of these forms of hyperparathyroidism requires more thorough research on the prognosis of survival, duration and quality of life, and the risk of developing associated diseases in these patients.
About the Authors
I V VORONENKOI.M.Sechenov Moscow Medical Academy
Russian Federation
A L SYRKIN
I.M.Sechenov Moscow Medical Academy
Russian Federation
L Ya ROZhINSKAYa
Endocrinology Research Centre
Russian Federation
G A MEL'NIChENKO
Endocrinology Research Centre
Russian Federation
References
1. Palmer M., Adami H.O., Bergstrom R., Akerstrrom G. 1987 Mortality after surgery for PHPT. Surgery. 102:1-7.
2. Hedback G., Tisell L.E., Bengtsson B.A., Hedman I., Oden A. 1990 Premature death in patients operated on for PHPT. World J Surg. 14: 829-835.
3. Hedback G., Oden A. 1998 Increased risk of death from PHPT-an update. Eur J Clin Invest. 28:271-276.
4. Wermers R.A., Khosla S., Atkinson E.J., et al. 1998 Survival after diagnosis of PHPT: a population based study. Am J Med. 104:115-122
5. Leifsson B.G., Ahren B. 1996 Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab. 81:2149-2153.
6. Uden P., Tibblin S. Mortality in patients surgically treated for primary hyperparathyroidism due to solitary adenoma Ann Chir Gynaecol 1990;79: 123-128
7. Palmer M., Adami H.O., Bergstrom R., et al. Survival and renal function in untreated hypercalcemia. Population-based cohort study with14 years of follow-up Lancet 1987;10:59-62
8. Anderson P., Rydberg E., Willenheimer R. Primary hyperparathyroidism and heart disease - a review. Europ Heart J 2004;Vol25, N20, 1776-1787.
9. Levin A., Li Y.C. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int 2005; 68(5): 1973-81
10. Nasri H., Baradaran A. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. J Ayub Med Coll Abbottabad 2004; 16(2): 3-8.
11. Kim H.W., Park C.W., Shin Y.S., et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 2006; 102(1): 21-9.
12. De Boer I.H., Gorodetskaya I., Young B., Hsu C.Y., Chertow G.M. The severity of hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race dependent, and associated with cardiovascular disease. J Am Soc Nephrol 2002; 13(11): 2762-9.
13. Piovesan A., Molineri N., Casasso F., et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy Clin Endocrinol 1999;50:321-328.
14. Dominiczak A.F., Lyall F., Morton J.J., et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism Clin Sci 1990;78: 127-132.
15. Lind L., Hvarfner A., Palmer M., Grimelius L., Akerstrom G. & Ljunghall S. Hypertension in primary hyperparathyroidism in relation to histopathology. European Journal of Surgery 1991;157: 457-459.
16. Lumachi F., Ermani M., Luisetto G. Relationship between serum parathyroid hormone, serum calcium and arterial blood pressure in patients with primary hyperparathyroidism: results of a multivariate analysis. Eur J Endocrinol 2002; 146: 643-647.
17. Nainby-Luxmoore J.C., Langford H.G., Nelson N.C., Watson R.L., Barnes TYA case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab. 1982 Aug;55(2):303-6.
18. Uden P., Chan A., Duh Q.Y., Siperstein A., Clark O.H. Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg. 1992 Jul-Aug;16(4):791-7; discussion 798.
19. Voss D.M. and Drake E.H. Cardiac manifestations of hyperparathyroidism, with presentation of a previously unreported arrhythmia. Am Heart J 1967; 72: 235-239.
20. Kearney P., Reardon M., O'Hare J. Primary hyperparathyroidism presenting as torsade de pointes. Br Heart J 1993; 70: 473.
21. Chang C.J., Chen S.A., Tai C.T., et al. Ventricular tachycardia in a patient with primary hyperparathyroidism. Pacing Clin Electrophysiol 2000; 23: 534-537.
22. Ochetta E., Bortnic M., Magnani A. et al. Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death. Europace 2004; 6(3): 184-188.
23. Nuzzo V., Tauchmanova L., Fonderico F., et al. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism Eur J Endocrinol 2002;147:453-459.
24. Suwelack B., Gerhardt U., Witta J., Hillebrandt U., Hohage H. Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation.Am J Hypertens. 2001 Oct;14(10):1012-8.
25. Smith J.C., Page M.D., John R. et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol and Methabolism 2000; 85(10):3515-3519.
26. Rubin M.R., Mauer M.S., McMahon D.J., et al. Arterial Stffeness in mild primary hyperparathyroidism. J clinical endocrinology 2005; 90:3326.
27. Kosch M., Hausberg M., Vormbrock K., et al. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism Am J Hypertens 2000;13:759-764.
28. Kosch M., Hausberg M., Vormbrock K., et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy Cardiovasc Res 2000;47:813-818.
29. Nilsson I.L., Aberg J., Rastad J., et al. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy Surgery 1999;129:1049-1055.
30. Silverberg S.J. Cardiovascular disease in primary hyperparathyroidism. J Clin Endocrino and Metabolism 2000; Vol.85, N10: 3513-3514.
31. Stefenelli T., Mayr H., Bergler-Klein J., et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy Am J Med 1993;95:197-202.
32. Stefenelli T., Abela C., Frank H., et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up J Clin Endocrinol Metab 1997;82:106-112.
33. Lаngle F., Abela C., Koller-Strametz J., et al. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data World J Surg 1994;18:619-624.
34. Dalberg K., Brodin L.A.A., Juhlin-Dannfelt A., et al. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study Eur J Surg 1996;162:171-176.
35. Almqvist E.G., Bondeson A.G., Bondeson L., et al. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy Surgery 2002;132:1126-1132.
36. Schluter K.-D. PTH and PTHrP: Similar structures but different functions. News Physiol Sci. 1999;14:243-249.
37. Deftos L.J., Burton D.W., Brandt D.W. Parathyroid hormone-like protein (PLP) is a secretory product of atrial myocytes. J Clin Invest. 1993;92:727-735.
38. Bui T.D., Shallal A., Malik A.N., Al-Mahdawi S., Moscoso G., Bailey M.E.S., Burton P.J.B., Moniz C. Parathyroid hormone related peptide gene expression in human fetal and adult heart. Cardiovascular Res. 1993;27:1204-1208.
39. Burton D.W., Brandt D.W., Deftos L.J. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology. 1994;135:253-261.
40. Schluter K.-D., Katzer C., Frischkopf K., et al. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells Circ Res 2000;86:946-951
41. Pirola C.J., Wang H.M., Strgacich M.I., et al. Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro Endocrinology 1994;134:2230-2236.[
42. Schluter K.D., Weber M., Piper H.M. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity Biochem J 1995;310:439-444.
43. McCarty M.F. Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy. Med Hypotheses; 2005; 64(5): 1015-21.
44. Schluter K.D., Piper H.M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes Am J Physiol 1992;263:H1739-H1746.
45. Saks V.A., Belikova Y.O., Kuznetsov A.V., et al. Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy Am J Physiol 1991;261:30-38.
46. Bogin E., Massry SG., Harary I. Effect of parathyroid hormone on rat heart cells J Clin Invest 1981;67:1215-1227.
47. Ogino K., Burkhoff D., Bilezikian J.P. 1995 The hemodynamic basis for the cardiac effect of parathyroid hormone and parathyroid hormone-related protein. Endocrinology 136:3024-3030.
48. Baczynski R., Massry S.G., Kohan R., et al. Effect of parathyroid hormone on myocardial energy metabolism in the rat Kidney Int 1985;27: 718-725.
49. Smogorzewski M., Perna A.F., Borum P.R., et al. Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF Kidney Int 1998;34:797-803.
50. Bogin E., Levi J., Harary I., et al. Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria Miner Electrolyte Metab 1982;7: 151-156.
51. Perna A.F., Smogorzewski M., Massry S.G. Effects of verapamil on the abnormalities in fatty acid oxidation of myocardium Kidney Int 1989;36: 453-457.
52. Shimoyama M., Ogino K., Furuse Y., et al. Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart J Cardiovasc Pharmacol 2001;38:491-499.
53. Hara M., Liu Y.M., Zhen L., et al. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential Circulation 1997;18;96:3704-3709.
54. Hanson A.S., Linas S.L. Parathyroid hormone|adenylate cyclase coupling in vascular smooth muscle cells. Hypertension 1994; 23: 468-475.
55. Pang P.K., Yang M.C., Tenner T.E., et al. Cyclic AMP and the vascular action of parathyroid hormone. Can J Physiol Pharmacol 1986; 64(12): 1543-7.
56. Nickols G.A., Metz M.A., Cline Jr. W.H. Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased adenosine 3',5'-monophasphate and relaxation of vascular smooth muscle. Endocrinology 1986: 119: 349-356.
57. Schleiffer R., Bergmann C., Pernot F., et al. Parathyroid hormone acute vascular effect is mediated by decreased Ca2+ uptake and enhanced cAMP level Mol Cell Endocrinol 1989;67:63-71.
58. Pang P.K., Yang M.C., Sham J.S. Parathyroid hormone and calcium entry blockade in a vascular tissue Life Sci 1988;42:1395-1400.
59. Trizna W., Edwards R.M. Relaxation of renal arterioles by parathyroid hormone and parathyroid hormone-related protein Pharmacology 1991;42: 91-96.
60. Nakamura R., Watanabe T.X., Sokabe H. Acute hypotensive action of parathyroid hormone (1-34) fragments in hypertensive rats. Proc Soc Exp Biol Med 1981; 168: 168-171.
61. Pang P.K., Tenner T.E. Jr., Yee J.A., Yang M., Janssen H.F. Hypotensive action of parathyroid hormone preparations on rats and dogs. ProcNadAcad Sci USA 1980,77:675-678.
62. Jespersen B., Randlov A., Abrahamsen J., et al. Effects of PTH (1-34) on blood pressure, renal function, and hormones in essential hypertension:the altered pattern of reactivity may counteract raised blood pressure Am J Hypertens 1997; 10: 1356-1367.
63. Fliser D., Franek E., Fode P., et al. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans Nephrol Dial Transpl 1997;12:933-938.
64. Hulter H.N., Melby J.C., Peterson J.C., Cooke C.R. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens. 1986 Dec;2(4):360-70.
65. Levy D., Garrison R.J., Savage D.D., et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study Ann Intern Med 1989;110:101.
66. Ghali J.K., Liao Y., Simmons B., et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease Ann Intern Med 1992;117:831-836.
67. Nilsson I.L., Aberg J., Rastad J., et al. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy Surgery 2000;128:895-902.
68. Barletta G., De Feo M.L., Del Bene R., et al. Cardiovascular effects of parathyroid hormone: a study in healty subjects and normotensive patients with mild primary hyperparathyroidism J Clin Endocrinol Metab 2000;85:1815-1821.
69. Dahlof B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies Am J Hypertens 1992;5:95-110.
70. Aurigemma G.P., Devereux R.B., Wachtell K., et al. Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment Am J Hypertens 2003;16:180-186.
71. Nppi S., Saha H., Virtanen V., et al. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy Cardiology 2000;93:229-233.
72. Stefenelli T., Abela C., Frank H., et al. Time course of regression of left ventricular hypertrophy after successful parathyroidectomy Surgery 1997;121: 157-161.
73. Hui Y., Hao Y., Chen X., et al. Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension Chin Med J 1996;109: 885-887.
74. Vestergaard H., OStergaard Kristensen L. Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease World J Surg 2002;26:657-660.
75. Hedbaeck G., Odaen A. Persistent disease after surgery for primary hyperparathyroidism: the long-term outcome Eur J Endocrinol 2004;150:19-25.
76. Grollier G., Hurault de Ligny B, et al. So-caled uremic heart disease. Arch Mal Coeur Vaiss 1990; 83(3): 401-6.
77. Hampi H., Sternberg C., Berweck S., et al. Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol 2002; 58, Suppl 1: 73-96.
78. Harnett J.D., Parfrey P.S., Griffiths S.M., et al. Left ventricular hypertrophy in end-stage renal disease. Nephron 1988; 48(2): 107-15.
79. London G.M., Marchis S.J., Guerin A.P., Metivier F. Contributive factors to cardiovascular hypertrophy in renal failure. Am J Hypertens 1989; 2: 261-263.
80. Lemmila S., Saha H., Virtnen V., et al. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 1998; 18(5): 404-10.
81. Hara S., Ubara Y., Arizono K., et al. Relation between parathyroid hormone and cardiac function in long-term hemodyalisis patients. Miner Electrolyte Metab 1995; 21(1-3): 72-6.
82. Gafter U., Battler A., Ekdar M., et al. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron 1985; 41(1): 30-3.
83. Sato S., Ohta M., Kawaguchi Y., et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995; 21(1-3): 67-71.
84. Park C.W., Oh Y.S., Shin Y.S., Kim S.M., et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodyalisis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33(1): 73-81.
85. Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003; 24 (22): 2054-2060.
86. Bauwens F.R., Duprez D.A., De Buyzere M.L., et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension Am J Cardiol 1991;68:925-929.
87. de Simone G., Pasanisi F., Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy Hypertension 2001;38:13-18
88. Ringe J.D. Reversible hypertension in primary hypertension in primary hyperparathyroidism - pre and postoperative blood pressure in 75 cases. Klin Wochenschr 1984; 62(10):465-9.
89. Richards A.M., Espiner E.A., Nichols M.G. et al. Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. J Hypertens 1988; 6(9):747-52.
90. Ohara N., Hiramatsu K., Shigematsu S. et al. Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner Electrolyte Metab 1995; 21(1-3):63-6.
91. Nagashima M., Hashimoto K., Shinsato T., et al. Marked improvement of left ventricular function after parathyroidectomy in a hemodialysis patient with secondary hyperparathyroidism and left ventricular dysfunction. Circ J 2003; 67(3): 269-72.
92. Goto N., Tominaga Y., Matsuoka S., Sato T., et al. Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol 2005; 9(3):138-41.
93. Ianetti E., Carpinteri G., Vitale M., et al. Hyperparathyroidism, therapy with erythropoetin, malnutrition and systolic function in hemodialysis: echocardiography study. Recenti prog Med 2000; 91(12):632-5.
94. Zucchelli P., Santoro A., Zucchelli A., et al. Long-term effect of parathyroidectomy on cardiac and autonomic nervous system functions in hemodialysis patients. Nephrol Dial Transplant 1988; 3(1):45-50.
95. Raitakari O.T. 1999 Imaging of subclinical atherosclerosis in children and young adults. Ann Med 31(Suppl 1):33-40.
96. O'Leary D.H., Polak J.F., Krinmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. 1999 Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340: 14-22.
97. Kosch M., Hausberg M., Barenbrock M., et al. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy Clin Nephrol 2001;55:303-308.
98. Neunteufl T., Katzenschlager R., Abela C., et al. Impairment of endothelium-independent vasodilation in patients with hypercalcemia Cardiovasc Res 1998;40:396-401.
99. Fallo F., Camporese G., Capitelli E., et al. Ultrasound evaluation of carotid artery in primary hyperparathyroidism J Clin Endocrinol Metab 2003;88:2096-2099.
100. Arnett D.K., Evans G.V. & Riley W.A. Arterial stiffness: a new cardiovascular risk factor. American Journal of Epidemiology1994 140 669-682.
101. Glasser S.P., Arnett D.K., McVeigh G.E., Finkelstein S.M., Bank A.J., Morgan D.J. et al. Vascular compliance and cardiovascular disease:a risk factor or a marker. American Journal of Hypertension 1997;10 1175-1189.
102. Nilsson H., Rastad J., Johanson K., Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001; 130(6): 986-90.
103. Morfis L., Smerdely P., Howes L.G. Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens. 1997 Nov;15(11):1271-6.
104. Young E.W., McCarron D.A., Morris C.D. Calcium regulating hormones in essential hypertension. Importance of gender.Am J Hypertens. 1990 Aug;3(8 Pt 2):161-166.
105. St John A., Dick I., Hoad K., Retallack R., Welborn T. & Prince R. Relationship between calcitrophic hormones and blood pressure in elderly subjects. European Journal of Endocrinology 1994; 130:446-450.
106. Brickman A.S., Nyby M.D., Von hungen K., et al. Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension. 1990 Nov;16(5):515-22.
107. Fardella C. & Rodriguez-Portales J.A. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension. Journal of Endocrinological Investigation 1995; 18: 827-832.
108. Sancho J.J., Rouco J., Riera-Vidal R. & Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World Journal of Surgery 1992: 16:732-736.
Review
For citations:
VORONENKO I.V., SYRKIN A.L., ROZhINSKAYa L.Ya., MEL'NIChENKO G.A. HYPERPARATIROSIS AND CARDIOVASCULAR SYSTEM PATHOLOGY. Osteoporosis and Bone Diseases. 2006;9(2):33-41. (In Russ.) https://doi.org/10.14341/osteo2006233-41
Views:
412
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
